Company Filing History:
Years Active: 2013-2018
Title: **Sanjay Pandurang Gawade: Innovator in Pharmaceutical Patents**
Introduction
Sanjay Pandurang Gawade is a prominent inventor based in Mumbai, India, known for his significant contributions to the field of pharmaceuticals. With two registered patents to his name, Gawade has made noteworthy advancements that aim to improve the treatment of serious health conditions such as thrombo-embolism and cardiovascular diseases.
Latest Patents
Gawade's latest patents include innovative anti-thrombotic compounds, specifically targeting the treatment and prophylaxis of thrombo-embolism and cardiovascular diseases. His patents detail new compounds, including (7aS,2'S)-2-oxoclopidogrel and its pharmaceutically acceptable salts. Furthermore, his work on solid forms of methyl (7aS,2'S)-2-(2-chlorophenyl)-2-(2,4,5,6,7,7a-hexahydrothieno[3,2-c]-5-pyridin-2-one)acetate signifies his commitment to advancing medical science through effective pharmacological solutions.
Career Highlights
Sanjay Gawade is employed at Ipca Laboratories Limited, a leading pharmaceutical company that emphasizes innovation in drug development. His work encapsulates rigorous research and development efforts that have contributed to the enhancement of therapeutic options available in the market.
Collaborations
Throughout his career, Gawade has collaborated with esteemed colleagues, including Ashok Kumar and Satish Rajanikant Soudagar. These partnerships have facilitated a dynamic teamwork environment that fosters creativity and the development of groundbreaking pharmaceutical formulations.
Conclusion
Sanjay Pandurang Gawade stands out as a significant figure in the realm of pharmaceutical inventions. His innovative patents not only showcase his technical expertise but also contribute to the broader effort in tackling critical health challenges. As such, Gawade exemplifies the spirit of invention and the impact one individual can have on the field of medicine and healthcare.